Multicenter Hologic Tomosynthesis Study

NACompletedINTERVENTIONAL
Enrollment

3,521

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

September 30, 2011

Study Completion Date

April 30, 2012

Conditions
Breast Cancer
Interventions
DEVICE

Hologic Selenia Dimensions Digital Breast Tomosynthesis System

Subjects are exposed to the same number of investigational images collected on the investigational device (Selenia Dimensions Full Field Digital Mammography System). Subject enrollment occurs at the time subjects are being imaged for their standard of care mammographic work up (either screening mammogram or scheduled biopsy). All subjects undergoing a biopsy procedure will be imaged on the investigational device prior to their procedure.

Trial Locations (22)

14620

Elizabeth Wende Breast Clinic, Rochester

15213

Magee Women's Hospital, Pittsburgh

17403

York - Women's Imaging at Apple Hill, York

19141

Albert Einstein Medical Center, Philadelphia

22908

University of Virginia, Charlottesville

33021

Memorial Florida, Hollywood

33486

Boca Raton Community Hospital, Boca Raton

44106

University Hospitals Case Medical Center, Cleveland

45912

University of Cincinnati, Cincinnati

49503

Spectrum Health, Grand Rapids

55905

Mayo Clinic, Rochester

60068

Luthern General - Advocate Health Care, Chicago

63110

Barnes Jewish, St Louis

75039

UTSW Center for Breast Care, Dallas

77074

Memorial Hermann/ Memorial City, Houston

80111

Invision/Sally Jobe, Greenwood Village

84175

Intermountain Medical Imaging, Murray

85251

Scottsdale Medical Imaging Ltd. (SMIL), Scottsdale

92663

Hoag Memorial Hospital, Newport Beach

95817

UC Davis, Sacramento

02114

Massachusetts General Hospital, Boston

05401

Fletcher Allen Health Care, Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Hologic, Inc.

INDUSTRY

NCT00971087 - Multicenter Hologic Tomosynthesis Study | Biotech Hunter | Biotech Hunter